Product
Mebeverine
2 clinical trials
2 indications
Indication
Irritable Bowel SyndromeIndication
Irritable Bowel Syndrome with DiarrheaClinical trial
Multicenter, Randomized, Parallel-group, Open-label, Comparative Clinical Study to Evaluate Efficacy and Safety of Mebeverine+Simethicone Fixed-dose Combination Versus Duspatalin® (Mebeverine) and Versus Espumisan® (Simethicone) in Patients With Functional Bowel Disorders With Abdominal Pain and Excess Gas FormationStatus: Completed, Estimated PCD: 2021-05-18
Clinical trial
To Compare the Efficacy of (Rifaximin + Mebeverine), (Rifaximin + Amitriptyline), and (Rifaximin + Psyllium Husk) in Irritable Bowel Syndrome Associated With DiarrheaStatus: Completed, Estimated PCD: 2023-03-27